retatrutide nejm 2023 obesity trial ly3437943 just posted the biggest weight-loss numbers ever recorded for a drug — 28.3% (≈70 lb) average in Phase 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric First Retatrutide phase 3 data,

What Consumers Should Know About GLP-1 Evidence and FeelGood's Brand-Stated Outcome Claims There are two separate issues consumers should not confuse: the clinical evidence for FDA-approved GLP-1 medications in appropriate patients, and FeelGood's brand-stated outcome claims for its own telehealth program

Compounded GLP-1 drugs are versions of GLP-1 medications created by compounding pharmacies rather than manufactured by pharmaceutical companies

More hunger means overeating

Posters were promotional, commemorative, collectible, and especially expressive

High accuracy for better decision-making The Dexcom G7 15 Day sensor is designed to provide users with highly accurate glucose readings